Factors influencing the prognosis of patients with intrahepatic cholangiocarcinoma

Acta Gastro-Enterologica Belgica

Volumn 75, Issue 2, 2012, Pages 215-218

  Liu, Zhi Heng ^a   Chen, Zhong ^b   Ma, Long Le ^a   Li, Xue Hua ^a   Wang, Le Xin ^c  

^a LIAOCHENG PEOPLE'S HOSPITAL   (China)

^b JINAN MILITARY GENERAL HOSPITAL   (China)

^c CHARLES STURT UNIVERSITY   (Australia)

Author keywords

Hepatectomy; Intrahepatic cholangiocarcinoma; Lymphnode metastasis; Mortality; Prognosis

Indexed keywords

ALPHA FETOPROTEIN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; HEPATITIS B SURFACE ANTIGEN;

ABDOMINAL DISCOMFORT; ARTICLE; BILE DUCT CARCINOMA; BILE DUCT STONE; CANCER SURGERY; CANCER SURVIVAL; FATIGUE; FEMALE; HEPATOMEGALY; HUMAN; LAPAROTOMY; LIVER RESECTION; LOBECTOMY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREDICTION; PROGNOSIS; SCHISTOSOMIASIS; SURVIVAL RATE; SURVIVAL TIME; TELECONSULTATION;

ADULT; AGED; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CA-19-9 ANTIGEN; CHOLANGIOCARCINOMA; FEMALE; HEPATECTOMY; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS;

EID: 84863594514     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. POULTSIDES G.A., ZHU A.X., CHOTI M.A., PAWLIK T.M. Intrahepatic cholangiocarcinoma. Surg. Clinics North Am., 2010, 90 (4): 817-837.
2. ENDO I., GONEN M., YOPP A.C., DALAL K.M., ZHOU Q., KLIMSTRA D. et al. Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann. Surg., 2008, 248 (1): 84-96.
3. TAMANDL D., HERBERGER B., GRUENBERGER B., PUHALLA H., KLINGER M., GRUENBERGER T. Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma. Ann. Surg. Oncol., 2008, 15 (10): 2787-2794.
4. JIANG B.G., SUN L.L., YU W.L., TANG Z.H., ZONG M., ZHANG Y.J. Retrospective analysis of histopathologic prognostic factors after hepatectomy for intrahepatic cholangiocarcinoma. Cancer J., 2009, 15 (3): 257-261.
5. LANG H., SOTIROPOULOS G.C., SGOURAKIS G., SCHMITZ K.J., PAUL A., HILGARD P. et al. Operations for intrahepatic cholangiocarcinoma: single-institution experience of 158 patients. J. Am. Coll. Surg., 2009, 208 (2): 218-228.
6. LANTHALER M., BIEBL M., STRASSER S., WEISSENBACHER A., FALKEIS C., MARGREITER R. et al. Surgical treatment of intrahepatic cholangiocarcinoma - a single center experience. Am. Surg., 2010, 76 (4): 411-417.
7. KAMPHUES C., SEEHOFER D., EISELE R.M., DENECKE T., PRATSCHKE J., NEUMANN U.P. et al. Recurrent intrahepatic cholangiocarcinoma: single-center experience using repeated hepatectomy and radiofrequency ablation. J. Hepatobiliary Pancreat. Sci., 2010, 17 (4): 509-515.
8. UENISHI T., KUBO S., YAMAZAKI O., YAMADA T., SASAKI Y., NAGANO H. et al. Indications for surgical treatment of intrahepatic cholangiocarcinoma with lymph node metastases. J. Hepatobiliary Pancreat. Sci., 2008, 15 (4): 417-422.
9. SHIRABE K., MANO Y., TAKETOMI A., SOEJIMA Y., UCHIYAMA H., AISHIMA S. et al. Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index. Ann. Surg. Oncol., 2010, 17 (7): 1816-1822.
10. CHOI S.B., KIM K.S., CHOI J.Y., PARK S.W., CHOI J.S., LEE W.J. et al. The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival. Ann. Surg. Oncol., 2009, 16 (11): 3048-3056.
11. CHO S.Y., PARK S.J., KIM S.H., HAN S.S., KIM Y.K., LEE K.W. et al. Survival analysis of intrahepatic cholangiocarcinoma after resection. Ann. Surg. Oncol., 2010, 17 (7): 1823-1830.
12. NATHAN H., PAWLIK T.M. Staging of intrahepatic cholangiocarcinoma. Current Opinion Gastroenterol., 2010, 26 (3): 269-273.
13. SHIRABE K., SHIMADA M., HARIMOTO N., SUGIMACHI K., YAMASHITA Y., TSUJITA E. et al. Intrahepatic cholangiocarcinoma: its mode of spreading and therapeutic modalities. Surgery, 2002, 131: S159-164.
14. HIROHASHI K., UENISHI T., KUBO S., YAMAMOTO T., TANAKA H., SHUTO T. et al. Macroscopic types of intrahepatic cholangiocarcinoma: clinicopathologic features and surgical outcomes. Hepatogastroenterol., 2002, 49: 326-329.
15. KAWARADA Y., YAMAGIWA K., DAS B.C. Analysis of the relationships between clinicopathologic factors and survival time in intrahepatic cholangio carcinoma. Am. J. Surg., 2002, 183: 679-685.
16. ERCOLANI G., GRAZI G.L., RAVAIOLI M., GRIGIONI W.F., CESCON M., GARDINI A. et al. The role of lymphadenectomy for liver tumors: further considerations on the appropriateness of treatment strategy. Ann. Surg., 2004, 239: 202-209.
17. YAMAMOTO M., TAKASAKI K., YOSHIKAWA T. Extended resection for intrahepatic cholangiocarcinoma in Japan. J. Hepatobiliary Pancreat. Surg., 1999, 6: 117-121.